Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Odyssey Therapeutics, Inc. before investing.

In this article, we go over a few key elements for understanding Odyssey Therapeutics, Inc.’s stock price such as:

• Odyssey Therapeutics, Inc.’s current stock price and volume
• Why Odyssey Therapeutics, Inc.’s stock price changed recently
• Upgrades and downgrades for ODTX from analysts
• ODTX’s stock price momentum as measured by its relative strength

About Odyssey Therapeutics, Inc. (ODTX)

Before we jump into Odyssey Therapeutics, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases. The company pipeline includes OD-001, an oral small molecule inhibitor of receptor-interacting protein kinase 2, which is in phase 2a trial for the treatment of ulcerative colitis; OD-002, an oral small molecule SLC15A4 inhibitor designed to block TLR7/8/9-mediated pathogenic inflammatory responses activation of interferon regulatory factor 5 (IRF5); OD-003, a protein therapeutic designed to agonize tumor necrosis factor receptor 2 selectively on Treg; a TSLP/IL-33 bispecific antagonist; an oral small molecule interleukin-1 receptor–associated kinase 4 scaffolding inhibitor; and a small molecule inhibitor of IRF5. The company was incorporated in 2021 and is headquartered in Boston, Massachusetts.

Want to learn more about Odyssey Therapeutics, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Odyssey Therapeutics, Inc..

Odyssey Therapeutics, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Odyssey Therapeutics, Inc.’s stock price was $18.930.

Odyssey Therapeutics, Inc. is up 2.77% from its previous closing price of $18.420.

During the last market session, Odyssey Therapeutics, Inc.’s stock traded between $18.040 and $19.250. Currently, there are approximately 5.66 million shares outstanding for Odyssey Therapeutics, Inc..

Odyssey Therapeutics, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Odyssey Therapeutics, Inc. Stock Price History

Odyssey Therapeutics, Inc.’s (ODTX) price is currently up 1.18% so far this month.

During the month of July, Odyssey Therapeutics, Inc.’s stock price has reached a high of $19.610 and a low of $15.100.

Over the last year, Odyssey Therapeutics, Inc. has hit prices as high as $20.300 and as low as $15.100.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Odyssey Therapeutics, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were analysts who downgraded Odyssey Therapeutics, Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Odyssey Therapeutics, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Odyssey Therapeutics, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Odyssey Therapeutics, Inc. (ODTX) by visiting AAII Stock Evaluator.

Relative Price Strength of Odyssey Therapeutics, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Odyssey Therapeutics, Inc. has a weighted four-quarter relative price strength of %, which translates to a Momentum Score of and is considered to be NA.

Want to learn more about how Odyssey Therapeutics, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Odyssey Therapeutics, Inc. Stock Price: Bottom Line

As of July 31, 2026, Odyssey Therapeutics, Inc.’s stock price is $18.930, which is up 2.77% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Odyssey Therapeutics, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.